Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)38-40
Number of pages3
JournalMultiple Sclerosis and Related Disorders
Volume34
DOIs
Publication statusPublished - Sep 2019

Cite this